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Background Methodology 
Findings 
Lessons from Existing Registries 
A number of key lessons can be learned from existing registries; most are common across 
registries, but the subjectivity of a dementia diagnosis is particularly problematic and 
while the timing is opportune, aspects of the Irish health environment are also challenging. 
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Patient registries provide data that enable the course of a disease to be observed, to 
identify inequities in service provision and use, to assess the efficacy of clinical 
outcomes, and to explore the impact of the condition on patients’ lives. Each is essential 
to informed clinical and policy decision-making and health economic assessment1.  
The Medical Research Charities Group (MRCG) and the Irish Platform for Patients’ 
Organisations, Science and Industry (IPPOSI) argue that patient registries should be 
“central to the planning, delivery and review of health care in Ireland”1. Although 
Ireland does not as yet have a national patient registry strategy, many registries already 
exist and more are in the process of development. 
In response to the very poor recording and coding of dementia across all care settings2, 
and the scarcity of data needed to inform clinical and policy decisions with regard to 
dementia, the Alzheimer Society of Ireland commissioned this evidence-based review of 
the feasibiity of creating a National Dementia Register for Ireland.  
  Aims & Objectives 
Review patient registry models in Ireland and dementia registries that exist in other 
jurisdictions and examine their function and operation. 
Identify the impact of relevant legal, ethical, clinical, technology, and financial issues 
crucial to the development of a national register. 
Provide evidence-based policy recommendations to progress the issue of improved 
recording structures for dementia in Ireland. 
1. Medical Research Charities Group (MRCG), & Irish Platform for Patients’ Organisations Science 
and Industry (IPPOSI). (2011). Towards a National Strategy for Patient Registries in Ireland: 
Considerations for Government.  
2. Cahill, S., O'Shea, E., & Pierce, M. (2012). Creating excellence in dementia care: a research 
review for Ireland's national dementia strategy.  
References 
1.Rapid review of policy documents, published research and grey 
literature pertaining to patient and to dementia registries.  
2.Semi-structured interviews (n=21) with national and international 
experts: clinical, policy, health informatics, legal, technical, 
international dementia registries and the National Cancer, Cystic 
Fibrosis, and Idiopathic Pulmonary Fibrosis Registries of Ireland. 
3.Focus groups (n=2) with representatives of the Irish Dementia 
Working Group (IDWG; n=9; Male=5, Mean age = 63.56 years). 
   Interviews and focus groups were audio-recorded, transcribed,   
anonymised and analysed using inductive content analysis. 
4. Personal communication with other experts (n=13) who were 
unavailable for formal interview. 
There is general agreement that patient registries have a role to 
play in national public health strategies. 
Successful registries capture data from the patient’s point of entry 
into the health system and across all subsequent interactions, and 
they illustrate the clear need for collaboration and data sharing. 
Existing Irish patient registries demonstrate that a lot can be 
achieved within the current limitations of the Irish health system. 
An Irish National Dementia Registry could feasibly address the need 
for more accurate and comprehensive dementia data. 
Conclusions 
Analysis of the expert interviews and focus groups revealed six 
themes and these are illustrated with anonymised direct quotes. 
Three high-level cross-cutting themes were also identified:  
1. Benefits and Risks  
2. Barriers and Facilitators  
3. Dementia-specific Challenges.  
 
“‘People with dementia 
may need things 
explained more in terms 
of storytelling or 
analogies… you need that 
skill”  [LE, consent] 
“We need to have the 
information to be able to 
plan appropriately” [PE, 
enhance policy] 
“The most important aspect is 
that it will provide a solid 
evidence-base on the population 
level burden of dementia” [HI, 
provide information] 
“The more information there is, 
the more learning and more 
understanding, and I think more 
awareness, acceptance” [IDWG, 
provide information] 
“It’s basically down to… 
seeing how you can impact 
the quality of the service” 
[RE, improve care] 
“‘It’s going to give us a 
little bit of power 
pushing for services and 
policy changes’”  [IDWG, 
enhance policy] 
Registry 
Function “I think the value of the 
registry also would be to 
actually try to improve the 
accuracy of the diagnosis” 
[CE, information and care] 
“Be able to compare our 
dementia data with those 
in other countries” [PE, 
improve care] 
“It allows us to understand 
the disease” [RE, support 
research] 
“… a cohort of people 
to take part in clinical 
research” [HI, 
support research] 
“The entry 
point should be 
a diagnosis of 
dementia” [PE, 
inclusion] 
“It comes back to, 
who are we 
collecting the 
registry for?” [HI, 
required data] 
“My main concern would be 
how do you define dementia? 
You come across GPs who 
underdiagnose and those who 
over diagnose” [RE, inclusion] 
“I think the state has a 
right to say… I 
certainly wouldn’t have 
a difficulty with that” 
[IDWG, consent] 
“You need to set up 
exactly what you 
think you want to 
look at first”  [RE, 
required data] 
Registry 
Data 
“It’s the 
accuracy [of the 
diagnosis] that’s 
key here” [CE, 
inclusion] 
“I don’t think you can 
have a valid system 
unless it has a 
mandate” [PE, consent] 
“You may be saying 
‘Yes’ at a very 
vulnerable moment” 
[IDWG, timing] 
“The opt-out route is probably 
the most open and practical 
approach” [IDWG, consent] 
“…trade-off 
between how much 
is anonymised and 
the quality of the 
research” [PE, 
consent] 
“I think you’d 
have to get the 
data in from 
clinicians” [CE, 
process] 
“Data collected by GPs 
… is one of the richest 
sources of clinical 
information” [HI, 
sources] 
“A universal patient 
identifier makes life 
easier” [RE, 
matching] 
“‘The biggest obstacle 
is getting access to 
various data sources.”  
[RE, process] 
Data 
Collection 
“If [collection] is a challenge 
in Sweden… it is going to be 
an incredible challenge for 
us [in Ireland]” [CE, sources] 
“I just see a unique 
identifier as a pre-
requisite” [PE, 
matching] 
“It took us 5 years to 
cross the 60% threshold” 
[RE, sources] 
“We are not really 
good at collecting 
information in primary 
care settings” [HI, 
sources] 
“I think there has to 
be some incentive to be 
able to get data from 
different organisations 
[HI, process] 
“[Buy-in] is key for 
the success of the 
registry.” [RE, 
process] 
“As long as it is managed, 
operated and overseen 
correctly, there shouldn’t 
be any great risks” [CE, 
access] 
“You’ve got to 
think about things 
like access 
controls to that 
information” [LE, 
access] 
“[HIQA] would 
want you to do a 
privacy impact 
assessment” [RE, 
access] 
“Respect a patient’s 
right to privacy and 
confidentiality”  [LE, 
privacy] 
Data 
Management 
“There’s a huge fear for 
people working … they’ll 
find ways to nudge you 
out the door]” [IDWG, 
access] 
The risks that 
someone will get 
that information 
and use it for their 
own benefit” [PE, 
access] 
“Couldn't people 
get access to it? 
Will I forever be 
labelled?” [IDWG, 
privacy] 
Policy Expert (PE) Irish Dementia Working 
Group (IDWG) 
Clinical Expert (CE) Research Expert (Res) 
Registry Expert (RE) Legal Expert (LE) 
“If It’s going to be 
national… have one 
body responsible for 
it” [PE, ownership] 
“We built up 
contacts with 
[another registry] 
at a very very 
early stage” [RE, 
structure] 
“Who will own and be 
responsible for the 
database?.. There might 
be very different data 
collected”  [HI, 
independence] 
Governance 
“You need a relatively 
small board… a good 
dynamic chair, someone 
who is going to push 
things along” [`RE, 
structure] 
“I think putting it automatically into the 
Department of Health, we are going to get 
more of the same” [HI, independence] 
“We looked for 
international standards, 
coding and operating 
procedures” [RE, quality] 
“Ours is a 
professional board, 
which I would very, 
very strongly urge” 
[RE, independence] 
“I think the 
biggest challenge 
is money” [RE, 
Cost] 
“You’ve got to 
balance… with 
having money 
for underlying 
provision” [PE, 
cost] 
“[Assisted Decision 
Making (Capacity) Act] will 
provide a legal structure 
for us” [IDWG] 
“Data protection 
should not be 
seen as a 
barrier” [LE] 
“There’s a Health 
Information Bill buried deep 
somewhere…but that’s been 
sitting in the DoH I’d say 
for about 10 years at this 
stage”” [RE] 
“The new decision 
making capacity 
legislation… will 
have a range of 
decision support 
mechanisms”  [LE] 
Legislation 
“There needs to be an 
information for health 
policy or piece of 
legislation” [HI] 
“[People with Dementia] 
may have signed an advance 
healthcare directive… Are 
they going on a register? 
Is it a healthcare decision 
or not?” [LE] 
“Danger of stigmatising 
dementia yet again by 
saying nobody has 
capacity” [Res, consent] 
Table 1. Active International population and clinical dementia registries 
Figure 1. Lessons learned from discussions with existing registries 
